Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2010-2-15
pubmed:abstractText
We assessed adult male and female awareness and acceptance of human papillomavirus (HPV) infection and vaccination for cervical cancer prevention, as well as factors associated with willingness to be administered the HPV vaccine. A nationwide population-based interview survey was conducted in Korea. One thousand male and female adults were included with random sampling. Despite the fact that awareness of HPV infection (13.3%) and the preventive effect of HPV vaccination (8.6%) were low, willingness to vaccinate against HPV (55.0%) was relatively high, especially with regard to participants' daughters (77.0%). Those who were informed about HPV infection (adjusted odds ratio, aOR=2.5 and 95% confidence interval, CI=1.1-5.3 in males; aOR=2.5 and 95% CI=1.5-4.2 in females) or vaccination (aOR=2.9 and 95% CI=1.1-7.6 in males; aOR=2.9 and 95% CI=1.6-5.4 in females), or who perceived a susceptibility to HPV infection (aOR=3.6 and 95% CI=1.9-6.8 in males; aOR=2.8 and 95% CI=1.6-5.0 in females) were more accepting of vaccination than those who did not. Appropriate knowledge transfer, guidance from a health professional, and reductions in the cost of the vaccine are key issues in promoting awareness of HPV infection and vaccination for cervical cancer prevention.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1873-2518
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1854-60
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea: a nationwide interview survey.
pubmed:affiliation
National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 411-760, Republic of Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't